Experimental Models to Study the Functions of the Blood-Brain Barrier

被引:5
作者
Lach, Andrzej [1 ,2 ]
Wnuk, Agnieszka [1 ]
Wojtowicz, Anna Katarzyna [2 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacol, Lab Neuropharmacol & Epigenet, PL-31343 Krakow, Poland
[2] Univ Agr, Fac Anim Sci, Dept Nutr Anim Biotechnol & Fisheries, PL-30059 Krakow, Poland
来源
BIOENGINEERING-BASEL | 2023年 / 10卷 / 05期
关键词
blood-brain barrier; in vitro modeling; permeability; HTS; TEER;
D O I
10.3390/bioengineering10050519
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The purpose of this paper was to discuss the achievements of in vitro modeling in terms of the blood-brain barrier [BBB] and to create a clear overview of this research area, which is useful in research planning. The text was divided into three main parts. The first part describes the BBB as a functional structure, its constitution, cellular and noncellular components, mechanisms of functioning and importance for the central nervous system, in terms of both protection and nourishment. The second part is an overview of parameters important in terms of establishing and maintaining a barrier phenotype that allows for formulating criteria of evaluation of the BBB in vitro models. The third and last part discusses certain techniques for developing the BBB in vitro models. It describes subsequent research approaches and models, as they underwent change alongside technological advancement. On the one hand, we discuss possibilities and limitations of different research approaches: primary cultures vs. cell lines and monocultures vs. multicultures. On the other hand, we review advantages and disadvantages of specific models, such as models-on-a-chip, 3D models or microfluidic models. We not only attempt to state the usefulness of specific models in different kinds of research on the BBB but also emphasize the significance of this area of research for advancement of neuroscience and the pharmaceutical industry.
引用
收藏
页数:30
相关论文
共 134 条
[31]   1α,25-Dihydroxyvitamin D3 Reduces Cerebral Amyloid-β Accumulation and Improves Cognition in Mouse Models of Alzheimer's Disease [J].
Durk, Matthew R. ;
Han, Kyung ;
Chow, Edwin C. Y. ;
Ahrens, Rosemary ;
Henderson, Jeffrey T. ;
Fraser, Paul E. ;
Pang, K. Sandy .
JOURNAL OF NEUROSCIENCE, 2014, 34 (21) :7091-7101
[32]   In silico prediction models for blood-brain barrier permeation [J].
Ecker, GF ;
Noe, CR .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) :1617-1628
[33]  
Elbrecht D. H., 2016, J RARE DIS RES TREAT, V1, P46, DOI [DOI 10.29245/2572-9411/2016/3.1026, 10.29245/2572-9411/2016/3.1026]
[34]   Pericyte Signaling in the Neurovascular Unit [J].
Fisher, Mark .
STROKE, 2009, 40 (03) :S13-S15
[35]   OCCLUDIN - A NOVEL INTEGRAL MEMBRANE-PROTEIN LOCALIZING AT TIGHT JUNCTIONS [J].
FURUSE, M ;
HIRASE, T ;
ITOH, M ;
NAGAFUCHI, A ;
YONEMURA, S ;
TSUKITA, S ;
TSUKITA, S .
JOURNAL OF CELL BIOLOGY, 1993, 123 (06) :1777-1788
[36]   Desmosome structure, composition and function [J].
Garrod, David ;
Chidgey, Martyn .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (03) :572-587
[37]   High and low permeability of human pluripotent stem cell-derived blood-brain barrier models depend on epithelial or endothelial features [J].
Girard, Stephane D. ;
Julien-Gau, Ingrid ;
Molino, Yves ;
Combes, Benjamin F. ;
Greetham, Louise ;
Khrestchatisky, Michel ;
Nivet, Emmanuel .
FASEB JOURNAL, 2023, 37 (02)
[38]   Utilization of membrane vesicle preparations to study drug-ABC transporter interactions [J].
Glavinas, Hristos ;
Mehn, Dora ;
Jani, Marton ;
Oosterhuis, Berend ;
Heredi-Szabo, Krisztina ;
Krajcsi, Peter .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (06) :721-732
[39]  
Gomes M.J., 2016, Concepts and Models for Drug Permeability Studies: Cell and Tissue based In Vitro Culture Models, V1st, P169, DOI [10.1016/B978-0-08-100094-6.00011-0, DOI 10.1016/B978-0-08-100094-6.00011-0]
[40]   Tight junction proteins [J].
González-Mariscal, L ;
Betanzos, A ;
Nava, P ;
Jaramillo, BE .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2003, 81 (01) :1-44